Nachrichten zu ThromboGenics NV
|
12.05.23
|
||
|
05.05.23
|
||
|
03.05.23
|
||
|
28.04.23
|
||
|
27.04.23
|
||
|
24.04.23
|
||
|
14.04.23
|
||
|
07.04.23
|
||
|
31.03.23
|
Oxurion Publishes 2022 Annual Report (GlobeNewswire)
|
|
|
31.03.23
|
||
|
24.03.23
|
||
|
21.03.23
|
||
|
14.03.23
|
||
|
09.03.23
|
Oxurion Receives Transparency Notification from Negma Group (GlobeNewswire)
|
|
|
02.03.23
|
Oxurion Receives Transparency Notification from Negma Group (GlobeNewswire)
|
|
|
02.03.23
|
||
|
02.03.23
|
Funding Program between Oxurion and Negma Ends (GlobeNewswire)
|
|
|
24.02.23
|
Oxurion Receives Transparency Notifications from Negma Group (GlobeNewswire)
|
|
|
24.02.23
|
||
|
17.02.23
|
||
|
17.02.23
|
Oxurion Receives Transparency Notifications from Negma Group (GlobeNewswire)
|
|
|
10.02.23
|
Oxurion Receives Transparency Notifications (GlobeNewswire)
|
|
|
10.02.23
|
||
|
23.11.22
|
Oxurion Further Improves THR-149 Patent Position (GlobeNewswire)
|
|
|
18.11.22
|
||
|
18.11.22
|
Oxurion Announces Interim Analysis for KALAHARI Trial (GlobeNewswire)
|
|
|
17.11.22
|
||
|
11.11.22
|
||
|
04.11.22
|
||
|
04.11.22
|
||
|
28.10.22
|
||
|
18.10.22
|
Oxurion To Participate in Upcoming Investor Conferences (GlobeNewswire)
|
|
|
30.09.22
|
||
|
12.09.22
|
||
|
07.09.22
|
Oxurion Publishes First Half 2022 Results (GlobeNewswire)
|
|
|
02.09.22
|
||
|
26.08.22
|
||
|
24.08.22
|
||
|
29.07.22
|
||
|
11.07.22
|
||
|
30.06.22
|
||
|
13.06.22
|
||
|
07.06.22
|
||
|
03.06.22
|
||
|
01.06.22
|
Oxurion to Participate in Upcoming Investor Conferences (GlobeNewswire)
|
|
|
31.05.22
|
||
|
25.05.22
|
||
|
24.05.22
|
||
|
09.05.22
|
||
|
11.04.22
|
Meistgelesene Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.